drugset / Trial / NCT04727034
Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy
Unknown
1800 enrolled
RenJi Hospital
Affiliated Hospital of Jiaxing University · collabShanghai East Hospital · collabThe First Affiliated Hospital of Nanchang University · collabThe Second Affiliated Hospital of Jiaxing University · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Propofol is the most commonly used intravenous anesthetic for painless gastroscopy, but propofol significantly inhibits the respiratory and circulatory systems. Therefore, the incidence of intraoperative hypoxemia and hypotension is high. Remazolam tosylate is an ultra-short-acting benzodiazepine drug, which has a mild inhibitory effect on the respiratory and circulatory systems and has anterograde amnesia. These advantages make remazolam tosylate very likely to replace propofol in painless gastroscopic anesthesia.
Timeline
- Start
- 2021-03-02
- Primary completion
- 2023-07-01
- Completion
- 2023-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Propofol | Small molecule | 1.5 mg/kg | Intravenous |
| Subject | Remimazolam | Small molecule | 0.15 mg/kg | — |
| Subject | Remimazolam | Small molecule | 0.2 mg/kg | — |